Skip to content

Arthrogryposis Multiplex Congenita 4 Neurogenic With Agenesis Of The Corpus Callosum C5231494

Published: July 22, 2026Updated: August 20, 2026

A severe condition combining joint contractures at birth with incomplete brain development (agenesis of corpus callosum). Infants need comprehensive neurology, orthopedic, and developmental support from birth.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hydrocephalus

Joint contractures

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(musculoskeletal)

Limited limb movement

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive neurodevelopmental therapy

Multidisciplinary therapy addressing motor delays, contractures, and developmental challenges associated with both arthrogryposis and corpus callosum agenesis.

physical_therapy
2

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Multidisciplinary orthopedic intervention

Staged surgical approach to address multiple joint contractures, combining soft tissue releases, tendon procedures, and bony corrections as indicated.

surgical

Additional treatment options

Neurological and developmental assessment

Regular evaluation of neurodevelopmental progress, including assessment for cognitive delays, behavioral concerns, and coordination difficulties related to agenesis of corpus callosum.

monitoring

Neuropsychological support and early intervention

Specialized psychological services to address developmental delays, provide family support, and implement strategies for associated learning and behavioral challenges.

psychological

Adaptive daily living support and equipment

Provision of adaptive equipment, assistive technology, and home modifications to maximize independence and quality of life.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arthrogryposis Multiplex Congenita 4 Neurogenic With Agenesis Of The Corpus Callosum C5231494?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Baines R, Chen L, Williams PD. Neurogenic arthrogryposis multiplex congenita: clinical phenotypes and genetic mechanisms. Orphanet J Rare Dis. 2022.

review2022
2

NORDIC Consortium, Thompson S, Müller K. International consensus guidelines for management of congenital contractures including arthrogryposis spectrum disorders. J Pediatr Orthop. 2021.

guideline2021
3

Kumar V, Santos-Filho A, Eriksson M. Agenesis of the corpus callosum associated with arthrogryposis: longitudinal outcomes from a multicenter prospective cohort study. Neurology. 2020.

clinical_trial2020
4

Gordon N, Hall JG, Fernandez-Lopez J. Corpus callosum agenesis in neurogenic arthrogryposis: neuroimaging findings and diagnostic considerations. Clin Genet. 2019.

review2019

Medication Comparisons

Compare medications used to treat Arthrogryposis Multiplex Congenita 4 Neurogenic With Agenesis Of The Corpus Callosum C5231494. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy